Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma

G. Porcile, M. Musso, F. Boccardo, R. Rosso, L. Santi

Research output: Contribution to journalArticlepeer-review

Abstract

Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalTumori
Volume65
Issue number2
Publication statusPublished - 1979

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma'. Together they form a unique fingerprint.

Cite this